Physician profile
Mallory Baker
NPI 1518209089
$1,711.06
in general payments reported to CMS, 2019-2025
28 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $94.81 · 2021: $123 · 2022: $262 · 2023: $465 · 2024: $392 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $392.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $330.29 | 2022-2025 | Ubrelvy, Vraylar, Qulipta |
| Sanofi-Aventis U.S. LLC | $87.84 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $70.03 | 2020-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $67.41 | 2019-2023 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $65.15 | 2024-2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $63.78 | 2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $59.77 | 2023-2025 | |
| Pfizer INC. | $57.08 | 2023-2025 | |
| Inspire Medical Systems, INC. | $53.82 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $45.65 | 2022-2023 | Shingrix, Bexsero |
| Cranial Technologies, INC | $45.37 | 2020-2023 | Doc Band |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.44 | 2021-2024 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $40.32 | 2020 | |
| Novartis Pharmaceuticals Corporation | $37.31 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $36.56 | 2019 | |
| Nevro Corp. | $26.04 | 2023 | Senza |
| Vbi Vaccine (Delaware) INC. | $24.33 | 2023 | Prehevbrio |
| Amgen INC. | $20.85 | 2024 | Krystexxa |
| Lundbeck LLC | $20.29 | 2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $19.76 | 2022 | |
| Angiodynamics, INC. | $19.71 | 2024 | Auryon Laser System 100-120 Vac |
| Esperion Therapeutics, INC. | $18.50 | 2021 | |
| Endogastric Solutions, INC | $15.75 | 2022 | |
| Sanofi Pasteur INC. | $13.46 | 2021 | |
| Sobi, INC | $13.25 | 2019 | |
| Eisai INC. | $12.42 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.